Loading...
NKGen Biotech, Inc. Warrants
NKGNW•NASDAQ
HealthcareBiotechnology
$0.03
$-0.07(-69.50%)
NKGen Biotech, Inc. Warrants (NKGNW) Stock Overview
Explore NKGen Biotech, Inc. Warrants’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for NKGNWStats details for NKGNW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for NKGNWAnalyst Recommendations details for NKGNW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.
CEO
Dr. Paul Y. Song M.D.
Employees
63
Headquarters
1790 Hughes Landing Boulevard, The Woodlands, TX
Founded
1970